ECSP003456A - GLUCOCORTICOID RECEIVER MODULATORS - Google Patents

GLUCOCORTICOID RECEIVER MODULATORS

Info

Publication number
ECSP003456A
ECSP003456A ECSP003456A ECSP003456A EC SP003456 A ECSP003456 A EC SP003456A EC SP003456 A ECSP003456 A EC SP003456A EC SP003456 A ECSP003456 A EC SP003456A
Authority
EC
Ecuador
Prior art keywords
compounds
present
glucocorticoid
modulators
receptor
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Bradley Paul Morgan
Kevin Kun-Chin Liu
Dow Robert Lee
Andrew Gordon Swick
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP003456 priority Critical patent/ECSP003456A/en
Publication of ECSP003456A publication Critical patent/ECSP003456A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

El presente invento proporciona compuestos no esteroides de fórmula I que son moduladores (es decir, agonistas y antagonistas) selectivos de un receptor esteroide, especificamente del receptor glucocorticoide. El presente invento proporciona también composiciones farmacéuticas que contienen estos compuestos, y métodos para usar estos compuestos con objeto de tratar animales que requieren una terapia con agonistas o antagonistas del receptor glucocoticoide. LOs moduladores del receptor glucocorticoide son útiles para tratar enfermedades tales como obesidad, diabetes, inflamación y otras enfermedades como las anteriormente descritas. El presente invento proporciona también productos intermedios y procedimientos para preparar estos compuestos (gráfico).The present invention provides nonsteroidal compounds of formula I that are selective modulators (i.e. agonists and antagonists) of a steroid receptor, specifically the glucocorticoid receptor. The present invention also provides pharmaceutical compositions containing these compounds, and methods for using these compounds in order to treat animals that require therapy with glucocoticoid receptor agonists or antagonists. The glucocorticoid receptor modulators are useful for treating diseases such as obesity, diabetes, inflammation and other diseases such as those described above. The present invention also provides intermediate products and processes for preparing these compounds (graph).

ECSP003456 2000-04-28 2000-04-28 GLUCOCORTICOID RECEIVER MODULATORS ECSP003456A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP003456 ECSP003456A (en) 2000-04-28 2000-04-28 GLUCOCORTICOID RECEIVER MODULATORS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP003456 ECSP003456A (en) 2000-04-28 2000-04-28 GLUCOCORTICOID RECEIVER MODULATORS

Publications (1)

Publication Number Publication Date
ECSP003456A true ECSP003456A (en) 2001-11-27

Family

ID=42041083

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP003456 ECSP003456A (en) 2000-04-28 2000-04-28 GLUCOCORTICOID RECEIVER MODULATORS

Country Status (1)

Country Link
EC (1) ECSP003456A (en)

Similar Documents

Publication Publication Date Title
CU23111A3 (en) GLUCOCORTICOID RECEIVER MODULATORS
PA8493701A1 (en) COMPOUNDS TO TREAT OBESITY
GT200000019A (en) INHIBITORS OF RECOVERY OF MONOAMINS FOR THE TREATMENT OF CNS DISORDERS.
ECSP034428A (en) CYCLOPENTHANOLS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND THEIR USE
BRPI0508820A (en) compounds as opioid receptor modulators
ECSP088402A (en) COMPOUNDS AND COMPOSITIONS CONTAINING DIARILAMINE, AND ITS USE AS MODULATORS OF C-KIT RECEIVERS
DOP2003000566A (en) CYCLALCANINDOLS WITH REPLACEMENT WITH FLUOR, COMPOSITIONS CONTAINING THESE COMPOUNDS AND PREPARATION METHODS FOR A MEDICINAL PRODUCT
ES2145774T3 (en) ADENOSINE DERIVATIVES THAT HAVE AGONIST ACTIVITY IN A2.
PA8587101A1 (en) NEW DERIVATIVES OF DIHYDROPIRIMIDO [4,5-D] PIRIMIDINONE REPLACED BY AMIINO, MANUFACTURE AND USE OF THE SAME AS PHARMACEUTICAL AGENTS
DOP2009000155A (en) DERIVATIVES OF FITTED HETERO-PENTACICLO-FENILO, PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS AND USES TO PREPARE A USEFUL MEDICINAL PRODUCT FOR THE TREATMENT OF A CONDITION MEDIATED BY P38
ECSP088511A (en) NEUROPEPTIDO-2 RECEIVER AGONISTS
BR112012009376B8 (en) solid pharmaceutical composition comprising a sglt-2 inhibitor and its pharmaceutical dosage form
UY31080A1 (en) PIRAZOL DERIVATIVES REPLACED WITH HETEROARILE USEFUL TO TREAT HYPERPROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS
UY27846A1 (en) CHEMICAL COMPOUNDS
CL2008000806A1 (en) Compounds derived from aza pyridopyrimidinone, with agonist activity of hm74a; preparation process of said compounds; pharmaceutical composition that includes them; and its use to prepare medicines for the treatment of atherosclerotic diseases, dyslipidemias, Alzheimer's, diabetes, among others.
UY28150A1 (en) THERAPEUTIC AGENTS
AR051904A1 (en) PEPTIDES WITH AGONIST ACTIVITY OF THE NEUROPEPTIDE-2 RECEIVER (Y2R)
UY27983A1 (en) NEW COMPOUNDS OF ISOTIAZOL AND ISOXAZOL AS INHIBITORS OF THE TRANSFORMING GROWTH FACTOR (TGF)
BR112022023025A2 (en) HTT MODULATORS TO TREAT HUNTINGTON'S DISEASE
AR047759A1 (en) FENIL DERIVATIVES - PIPERAZINE AS MODULATORS OF MUSCARNIC RECEPTORS
BR0313624A (en) 5ht2a receptor agonism for treatment of thermoregulatory dysfunction
HN2003000162A (en) DERIVATIVES OF ISOINDOLONE, PREPARATION PROCESS AND INTERMEDIATE COMPOUNDS OF THIS PROCESS, ITS USE AS MEDICATIONS, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
GT200900032A (en) OXAZOLIDONE DERIVATIVES AS PR MODULATORS
UY29181A1 (en) DERIVATIVES OF N-REPLACED BENCENOSULPHONAMIDS, COMPOSITIONS THAT CONTAIN THEM, PREPARATION PROCESSES AND APPLICATIONS
ES2169257T3 (en) NEW FUSIONED ISOQUINOLINAS AS LEGANDOS OF THE DOPAMINE RECEIVER.